How the right components, and their manufacturing setup, can meet the needs of an evolving market

Amid the evolution of the pharmaceutical industry, and more recently catalysed by the coronavirus (COVID-19) and its implications on drug demand, delivery and the supply chain, parenteral drugs are experiencing increased demand. Glenn Thorpe at Datwyler explains why parenteral allow for a controlled release — either gradual or instantaneous — that oral medication cannot always provide.